1. Andrade AR, Barros LL, Azevedo MFC, Carlos AS, Damiao A, Sipahi AM, Leite AZA. Risk of thrombosis and mortality in inflammatory bowel disease. Clin Transl Gastroenterol 2018; 9(4): 142 [PMID: 29618721 PMCID: PMC5886983 DOI: 10.1038/s41424-018-0013-8]
2. Taous A, Berri MA, Lamsiah T, Zainoun B, Ziadi T, Rouimi A. Cerebral venous thrombosis revealing an ulcerative colitis. Pan Afr Med J 2016; 23: 120 [PMID: 27279947 PMCID: PMC4885705 DOI: 10.11604/pamj.2016.23.120.9186]
3. Weng MT, Park SH, Matsuoka K, Tung CC, Lee JY, Chang CH, Yang SK, Watanabe M, Wong JM, Wei SC. Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study. Inflammatory bowel diseases 2018; 24(8): 1791-1800 [PMID: 29726897 DOI: 10.1093/ibd/izy058]
4. Lentz SR. Thrombosis in the setting of obesity or inflammatory bowel disease. Blood 2016; 128(20): 2388-2394 [PMID: 27856470 DOI: 10.1182/blood-2016-05-716720]
5.Higgins PD, Skup M, Mulani PM, Lin J, Chao J. Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2015; 13(2): 316-321 [PMID: 25038374 DOI: 10.1016/j.cgh.2014.07.017]
6. Meher LK, Dalai SP, Panda S, Hui PK, Nayak S. Unusual Case of Cerebral Venous Sinus Thrombosis in Patient with Ulcerative Colitis in Remission. J Clin Diagn Res 2016; 10(5): OD35-36 [PMID: 27437291 PMCID: PMC4948467 DOI: 10.7860/JCDR/2016/20105.7883]
7. Duman T, Uluduz D, Midi I, Bektas H, Kablan Y, Goksel BK, Milanlioglu A, Necioglu Orken D, Aluclu U, Group VS. A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST Study. J Stroke Cerebrovasc Dis 2017; 26(8): 1848-1857 [PMID: 28583818 DOI: 10.1016/j.jstrokecerebrovasdis.2017.04.020]
8. Katsanos AH, Katsanos KH, Kosmidou M, Giannopoulos S, Kyritsis AP, Tsianos EV. Cerebral sinus venous thrombosis in inflammatory bowel diseases. QJM : monthly journal of the Association of Physicians 2013; 106(5): 401-413 [PMID: 23243293 DOI: 10.1093/qjmed/hcs229]
9. Cognat E, Crassard I, Denier C, Vahedi K, Bousser MG. Cerebral venous thrombosis in inflammatory bowel diseases: eight cases and literature review. Int J Stroke 2011; 6(6): 487-492 [PMID: 22017824 DOI: 10.1111/j.1747-4949.2011.00620.x]
10. Liu Y, Ren D, Zhou Q, Gao L. Cerebral sinovenous thrombosis in a child with ulcerative colitis: A case report. Medicine (Baltimore) 2020; 99(2): e18649 [PMID: 31914047 PMCID: PMC6959932 DOI: 10.1097/MD.0000000000018649]
11. Ohta Y, Arai M, Nakagawa T, Akizue N, Ishikawa K, Hamanaka S, Koseki H, Taida T, Okimoto K, Saito K, Yoshihama S, Maruoka D, Matsumura T, Katsuno T, Kato N. Comparison of a novel predictor of venous thromboembolic complications in inflammatory bowel disease with current predictors. J Gastroenterol Hepatol 2019; 34(5): 870-879 [PMID: 30225931 DOI: 10.1111/jgh.14472]
12. Koutroumpakis EI, Tsiolakidou G, Koutroubakis IE. Risk of venous thromboembolism in patients with inflammatory bowel disease. Semin Thromb Hemost 2013; 39(5): 461-468 [PMID: 23629820 DOI: 10.1055/s-0033-1343886]
13. Cojocaru IM, Cojocaru M, Sapira V, Ionescu A, Tacu N. Cerebrovascular complications in patients with inflammatory bowel disease. Rom J Intern Med 2014; 52(1): 39-44 [PMID: 25000677]
14. Kirchgesner J, Nyboe Andersen N, Carrat F, Jess T, Beaugerie L, group Bs. Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study. Gut 2020; 69(5): 852-858 [PMID: 31446428 DOI: 10.1136/gutjnl-2019-318932]
15. Tatsuoka J, Igarashi T, Kajimoto R, Kobayashi M, Moro N, Suma T, Oshima H, Yoshino A. High-dose-infliximab-associated Cerebral Venous Sinus Thrombosis: A Case Report and Review of the Literature. Internal medicine (Tokyo, Japan) 2021 [PMID: 33678739 DOI: 10.2169/internalmedicine.6447-20]
16. Fayyaz M, Abbas F, Kashif T. The Role of Warfarin and Rivaroxaban in the Treatment of Cerebral Venous Thrombosis. Cureus 2019; 11(5): e4589 [PMID: 31309014 PMCID: PMC6609305 DOI: 10.7759/cureus.4589]
17. Richard S, Fairise A, Lacour JC, Ducrocq X. Cerebral venous thrombosis in inflammatory bowel diseases. Inflammatory bowel diseases 2010; 16(3): 366-367 [PMID: 19575358 DOI: 10.1002/ibd.20996]
18. Heo CM, Kim TJ, Kim ER, Hong SN, Chang DK, Yang M, Kim S, Kim YH. Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study. Sci Rep 2021; 11(1): 2025 [PMID: 33479464 PMCID: PMC7820465 DOI: 10.1038/s41598-021-81657-y]
19. Kaddourah O, Numan L, Jeepalyam S, Abughanimeh O, Ghanimeh MA, Abuamr K. Venous thromboembolism prophylaxis in inflammatory bowel disease flare-ups. Ann Gastroenterol 2019; 32(6): 578-583 [PMID: 31700234 PMCID: PMC6826077 DOI: 10.20524/aog.2019.0412]
20. Faye AS, Hung KW, Cheng K, Blackett JW, McKenney AS, Pont AR, Li J, Lawlor G, Lebwohl B, Freedberg DE. Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases 2020; 26(9): 1394-1400 [PMID: 31689354 PMCID: PMC7534414 DOI: 10.1093/ibd/izz269]